Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in Peru

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 23, Issue 1, 2008, Pages 1-6

  Winkler, Jennifer L ^a,b   Lewis, Kristen ^a,b   Aguila, Roberto Del ^c   Gonzales, Miguel ^d   Delgado, José Manuel ^d   Tsu, Vivien D ^a,b   Sellors, John W ^a,b  

^a PATH   (United States)

^b Pan American Health Organization ^*  (United States)

^c Pan American Health Organization   (Costa Rica)

^d PAN AMERICAN HEALTH ORGANIZATION   (Peru)

Author keywords

Diagnosis screening; Peru; Uterine cervical neoplasms

Indexed keywords

ACETIC ACID; CANCER; DEVELOPING WORLD; WOMENS HEALTH;

PERU; SAN MARTIN; SOUTH AMERICA;

EID: 42149109170     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892008000100001     Document Type: Article

References (12)

1. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide [Version 2.0]. Lyon, France: IARC Press; 2004. [IARC CancerBase No. 5]
2. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
3. Gage JC, Ferreccio C, Gonzales M, Arroyo R, Huivin M, Robles SC. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev. 2003;27(6):466-71.
4. Sellors JW, Sankaranarayanan R. Colposcopy and treatment of cervical intraepithelial neoplasia: A beginners' manual. Lyon, France: IARC Press; 2003.
5. Winkler JL, Tsu VD, Bishop A, Scott R, Sellors JW. Confirmation of cervical neoplasia using a hand-held, lighted magnification device. Int J Gynaecol Obstet. 2003;81(1):35-40.
6. Luciani S, Winkler J. Cervical cancer prevention in Peru: Lessons learned from the TATI demonstration project. Washington, D.C.: PAHO; 2006.
7. Almonte M, Ferreccio C, Winkler JL, Cuzick J, Tsu V, Robles S, Takahashi R, Sasieni P. Cervical screening by visual inspection, HPV testing, liquid-based, and conventional cytology in Amazonian Peru. Int J Cancer. 2007;121(4):796-802.
8. Carr KC, Sellors JW. Cervical cancer screening in low resource settings using visual inspection with acetic acid. J Midwifery Womens Health. 2004;49(4):329-37.
9. Sellors JW, Winkler JL, Kreysar DF. Illumination, optics, and clinical performance of a hand-held magnified visual inspection device (AviScope™): a comparison with colposcopy. J Acquir Immune Defic Syndr. 2004;37(Suppl 3):S160-6.
10. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet. 2003;361(9360):814-20.
11. Parashari A, Singh V, Sehgal A, Satyanarayana L, Sodhani P, Gupta MM. Low-cost technology for screening uterine cervical cancer. Bull World Health Organ. 2000;78(8):964-7.
12. Winkler JL, Tsu VD, Bishop A, Scott R, Sellors JW. Confirmation of cervical neoplasia using a hand-held, lighted magnification device. Int J Gynaecol Obstet. 2003;81(1):35-40.